Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, et al
Why Enforcement Against Compounded GLP-1 Has Escalated The legal landscape has changed dramatically since early 2025: FDA removed semaglutide from the drug shortage list in February 2025
With its powerful antioxidant action, pigmentation control and skin-brightening properties, Glutathione offers visible yet gentle results over time
[PubMed] [Springer] 97
Key topics include the significant shortages of GLP-1 drugs like Wegovy, Zepbound, and Ozempic, the rise of drug compounding as a response to these shortages, regulatory challenges and safety concerns with compounded GLP-1 drugs, and more